Skip to main content
Clinical Trials/NCT03099863
NCT03099863
Completed
Phase 4

Cytoscopic Antibiotic Irrigant to Reduce Postoperative Urinary Infection: A Randomized Controlled Study

MetroHealth Medical Center1 site in 1 country242 target enrollmentApril 2016

Overview

Phase
Phase 4
Intervention
Cystoscopy
Conditions
Urinary Tract Infections
Sponsor
MetroHealth Medical Center
Enrollment
242
Locations
1
Primary Endpoint
Urinary Tract Infection
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Postoperative urinary tract infections (UTIs) affect 20-30% of patients undergoing elective gynecologic surgery and have a significant socioeconomic impact and cost. Preoperative antibiotics, sterile operating techniques, postoperative antibiotic and non-antibiotic medical therapies have been utilized to attempt to decrease this rate with little improvement. Utilization of an intraoperative antibiotic cystoscopic irrigant may decrease postoperative UTIs. The investigators have designed a prospective randomized controlled study to evaluate the effectiveness of an antibiotic cystoscopic fluid in preventing postoperative urinary tract infections in women undergoing elective pelvic floor surgery with cystoscopy.

Registry
clinicaltrials.gov
Start Date
April 2016
End Date
June 2020
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jeffrey Mangel

Physician

MetroHealth Medical Center

Eligibility Criteria

Inclusion Criteria

  • Adult women at least 18 years of age
  • Elective Female Pelvic Medicine and Reconstructive Surgery or Gynecologic Minimally Invasive surgeries including hysterectomy, suburethral sling, and pelvic organ prolapse repair that require cystoscopy.

Exclusion Criteria

  • Surgeries that include: intradetrusor Botox, vaginal mesh excision, and fistula repair
  • Pregnancy
  • History of nephrolithiasis
  • Allergy to study medications
  • Congenital urogenital anomaly
  • Neurogenic bladder

Arms & Interventions

Standard Care

Standard cystoscopy with normal saline solution.

Intervention: Cystoscopy

Standard Care

Standard cystoscopy with normal saline solution.

Intervention: Cystoscopic Fluid/Placebo

Neosporin G. U. Irrigant

Standard cystoscopy with normal saline solution containing Neosporin® G.U. at a 1mL/1000mL concentration.

Intervention: Cystoscopic Fluid containing Neosporin G. U. Irrigant

Neosporin G. U. Irrigant

Standard cystoscopy with normal saline solution containing Neosporin® G.U. at a 1mL/1000mL concentration.

Intervention: Cystoscopy

Outcomes

Primary Outcomes

Urinary Tract Infection

Time Frame: 4 weeks

Urinary tract infection defined as positive urinalysis, urine culture, and/or positive lower urinary tract symptoms requiring antibiotic treatment.

Study Sites (1)

Loading locations...

Similar Trials